Skip to main content
Contact Us
Subscribe
E-Edition
79°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about REGN
Recent news which mentions REGN
< Previous
1
2
...
19
20
21
22
23
24
25
26
Next >
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Tickers
ADPT
AERI
AGIO
ALGS
Tags
SGMO
ICPT
Biotech
From
Benzinga
The Daily Biotech Pulse: Gilead-Merck Collaborate For Breast Cancer Study, Decision Day For ANI Pharma, Pfizer Gets Canadian Regulatory Nod, 3 IPOs
October 29, 2021
Tickers
A
ABBV
ABIO
ANIP
Tags
REGN
ABBV
RMD
From
Benzinga
Will Regeneron Be Worth More Than Amazon by 2030?
October 28, 2021
Tickers
AMZN
BNTX
MRNA
REGN
Tags
REGN
BNTX
AMZN
From
Motley Fool
1 Small-Cap Stock With 10X Potential
October 27, 2021
Tickers
GILD
NRXP
REGN
Tags
RLFT/F
NRXP
GILD
From
Motley Fool
Where Regeneron Pharmaceuticals Stands With Analysts
October 26, 2021
Tickers
REGN
Tags
Benzinga
BZI/AAR
REGN
From
Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
Tickers
ABBV
ADAP
ALIM
ALKS
Tags
ABBV
REGN
NVCR
From
Benzinga
Can AstraZeneca's COVID Antibody Therapy Win Against Regeneron and Eli Lilly?
October 23, 2021
Tickers
AZN
GSK
JNJ
LLY
Tags
JNJ
VIR
Market News
From
Motley Fool
The Daily Biotech Pulse: Athira CEO Resigns Over Doctored Research, Merck's Keytruda Snags First Approval For Breast Cancer In Europe, Minerva And Xilio IPOs
October 22, 2021
Tickers
ADPT
ATHA
AVRO
IBB
Tags
JNJ
ME
AVRO
From
Benzinga
Biotech Buyouts That Would Be Great for Investors
October 22, 2021
Tickers
CRSP
NTLA
REGN
VRTX
Tags
REGN
VRTX
CRSP
From
Motley Fool
Will Merck's COVID-19 Pill Sink Regeneron's and Eli Lilly's Antibody Therapy Sales?
October 22, 2021
Tickers
AZN
LLY
MRK
REGN
Tags
REGN
LLY
AZN
From
Motley Fool
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
Tickers
ABEO
ADMA
BHC
BMY
Tags
NURO
RNLX
SNY
From
Benzinga
Esperion Chops 40% Workforce As Launch Of Cholesterol Medication Falters
October 18, 2021
Tickers
AMGN
DSKYF
DSNKY
ESPR
Tags
Health Care
REGN
Biotech
From
Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Tickers
ABEO
ABT
AVDL
AVRO
Tags
Benzinga
Penny Stocks
VTYX
From
Benzinga
2 Best Biotech Stocks to Buy Right Now
October 18, 2021
Tickers
ABBV
AMGN
AZN
BMY
Tags
JNJ
MRK
Market News
From
Motley Fool
3 No-Brainer Biotech Stocks to Buy Right Now
October 16, 2021
Tickers
CRSP
PFE
REGN
SNY
Tags
VRTX
PFE
Market News
From
Motley Fool
Why Shares of Allogene Therapeutics, Beam Therapeutics, Intellia Therapeutics, and Schrödinger Are Volatile This Week
October 15, 2021
Tickers
ALLO
BEAM
CRSP
NTLA
Tags
Market News
NTLA
ALLO
From
Motley Fool
2 Cheap Growth Stocks That Could Be Even Better Buys in November
October 15, 2021
Tickers
BYND
REGN
Tags
Market News
BYND
REGN
From
Motley Fool
90,000 U.S. adult deaths from COVID-19 over the summer could have been prevented if victims had been vaccinated, study finds
October 14, 2021
Tickers
JNJ
MRNA
REGN
Tags
JNJ
MRNA
REGN
From
MarketWatch
Why Regeneron Shares Are Rising Today
October 14, 2021
Tickers
REGN
Tags
REGN
why it's moving
News
From
Benzinga
Pfizer Just Scored Another Key Regulatory Approval
October 14, 2021
Tickers
PFE
REGN
SNY
Tags
Market News
SNY
REGN
From
Motley Fool
3 Biotech Stocks You Can Buy and Hold for the Next Decade
October 13, 2021
Tickers
CRSP
MRK
NTLA
REGN
Tags
MRK
Market News
SGEN
From
Motley Fool
Expert Ratings For Regeneron Pharmaceuticals
October 12, 2021
Tickers
REGN
Tags
Analyst Ratings
Market News
Benzinga
From
Benzinga
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
Tickers
AZN
AZNCF
GSK
LLY
Tags
REGN
COVID/19 Coronavirus
Health Care
From
Benzinga
Why Humana Is Suing Biogen
October 09, 2021
Tickers
BIIB
BRK-A
BRK-B
HUM
Tags
Market News
BRK/B
HUM
From
Motley Fool
Regeneron Could Have a Big Catalyst Coming in 2022
October 09, 2021
Tickers
MRK
PFE
REGN
SNY
Tags
PFE
REGN
SNY
From
Motley Fool
Cramer Likes DraftKings, Skyworks, And These Automakers
October 07, 2021
Tickers
APLS
BGS
CPB
DKNG
Tags
TSLA
F
Small Cap
From
Benzinga
Is This The Turning Point for Inovio?
October 06, 2021
Tickers
AZN
INO
MRNA
REGN
Tags
REGN
AZN
MRNA
From
Motley Fool
Tesla and Merck Give Investors Some Hope
October 04, 2021
Tickers
GILD
GSK
JNJ
MRK
Tags
JNJ
VIR
Guidance
From
Benzinga
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
Tickers
AVIR
MRK
MRNA
NVAX
Tags
RHHBY
REGN
MRNA
From
Motley Fool
Here Are the Leaders in the Race to Develop a COVID-19 Pill
October 03, 2021
Tickers
AVIR
MRK
PFE
RDHL
Tags
RDHL
REGN
RHHBY
From
Motley Fool
< Previous
1
2
...
19
20
21
22
23
24
25
26
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.